Mark Strobeck is President and CEO of ROCKWELL MEDICAL, INC.. Currently has a direct ownership of 147,201 shares of RMTI, which is worth approximately $535,811. The most recent transaction as insider was on Oct 01, 2024, when has been sold 2,163 shares (Common Stock) at a price of $3.69 per share, resulting in proceeds of $7,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K
1.45% 3M change
165.39% 12M change
Total Value Held $535,811

Mark Strobeck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
SELL
Open market or private sale
$7,981 $3.69 p/Share
2,163 Reduced 1.45%
147,201 Common Stock
Mar 17 2024
SELL
Payment of exercise price or tax liability
$8,541 $1.4 p/Share
6,101 Reduced 3.92%
149,364 Common Stock
Mar 14 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 39.14%
155,465 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
55,465 Added 50.0%
55,465 Common Stock

Also insider at

WINT
WINDTREE THERAPEUTICS INC Healthcare
MS

Mark Strobeck

President and CEO
Wixom, MI

Track Institutional and Insider Activities on RMTI

Follow ROCKWELL MEDICAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RMTI shares.

Notify only if

Insider Trading

Get notified when an Rockwell Medical, Inc. insider buys or sells RMTI shares.

Notify only if

News

Receive news related to ROCKWELL MEDICAL, INC.

Track Activities on RMTI